J3263 Injection, toripalimab-tpzi, 1 milligrams
Also known as: toripalimab, Tuoyi, PD-1 inhibitor
Toripalimab-tpzi (Tuoyi) 1 milligram injection is a programmed death receptor-1 inhibitor used for advanced melanoma and other cancers as immunotherapy.
In Plain Language
cancer immunotherapy injection; melanoma treatment
Clinical Context
Indicated for unresectable or metastatic melanoma as a checkpoint immunotherapy. Blocks programmed death-1 pathway to enhance anti-tumor immunity. Requires monitoring for immune-related adverse events.
RVU Information
CPT J3263 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3263?
CPT J3263 (Injection, toripalimab-tpzi, 1 milligrams) is a J Codes (Drugs) code. Toripalimab-tpzi (Tuoyi) 1 milligram injection is a programmed death receptor-1 inhibitor used for advanced melanoma and other cancers as immunotherapy.
How is J3263 administered?
CPT J3263 is administered by a healthcare provider, typically via injection or infusion. Indicated for unresectable or metastatic melanoma as a checkpoint immunotherapy. Blocks programmed death-1 pathway to enhance anti-tumor immunity. Requires monitoring for immune-related adverse events. It is used by Oncology, Hematology/Oncology, Infusion Centers.
When is CPT J3263 used?
Indicated for unresectable or metastatic melanoma as a checkpoint immunotherapy. Blocks programmed death-1 pathway to enhance anti-tumor immunity. Requires monitoring for immune-related adverse events.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.